Founder Pathogenic Variant in LMNA with Diverse Phenotypic Manifestations in Mandibuloacral Dysplasia: Insights from a Turkish Cohort
Open Access
- 23 February 2026
- journal article
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 18 (1) , 129-137
Abstract
Mandibuloacral dysplasia (MAD) is a rare genetic disorder characterized by distinctive skeletal abnormalities, metabolic issues, and skin changes, often linked to pathogenic variants in the LMNA gene, which encodes lamin A/C. This study investigates a specific founder mutation within a Turkish cohort and explores its impact on phenotypic expressivity. We conducted a comprehensive analysis involving genetic testing for LMNA variants in patients diagnosed with MAD. Clinical evaluations documented a wide range of phenotypic features, including facial dysmorphism, skeletal anomalies, and metabolic abnormalities. We also collected family histories to assess inheritance patterns and potential environmental influences. Our findings identified a common founder mutation in the LMNA gene among the cohort, which was present in a significant percentage of participants. Notably, phenotypic expressivity varied significantly, with some individuals exhibiting classic MAD features, while others showed atypical manifestations, such as additional endocrine disorders and variable severity of skeletal anomalies. This variability underscores the complexity of the genotype-phenotype relationship. This study highlights the significance of the founder mutation in LMNA and its diverse phenotypic outcomes in MAD. Our results contribute to the understanding of how genetic mutations can lead to a spectrum of clinical presentations, emphasizing the necessity for personalized clinical approaches in managing this condition. Further research is warranted to elucidate the underlying mechanisms of phenotypic variability and to improve diagnostic and therapeutic strategies.Keywords
This publication has 15 references indexed in Scilit:
- Loss of MTX2 causes mandibuloacral dysplasia and links mitochondrial dysfunction to altered nuclear morphologyNature Communications, 2020
- Mandibuloacral dysplasia and LMNA A529V mutation in Turkish patients with severe skeletal changes and absent breast developmentClinical Dysmorphology, 2016
- Mandibuloacral dysplasia type A in childhoodAmerican Journal of Medical Genetics Part A, 2009
- The laminopathies: a clinical reviewClinical Genetics, 2006
- Alterations of nuclear envelope and chromatin organization in mandibuloacral dysplasia, a rare form of laminopathyPhysiological Genomics, 2005
- A Novel Homozygous Ala529ValLMNAMutation in Turkish Patients with Mandibuloacral DysplasiaThe Journal of Clinical Endocrinology & Metabolism, 2005
- Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasiaHuman Molecular Genetics, 2003
- Genetic and Phenotypic Heterogeneity in Patients with Mandibuloacral Dysplasia-Associated LipodystrophyThe Journal of Clinical Endocrinology & Metabolism, 2003
- A New Clinical Condition Linked to a Novel Mutation in Lamins A and C with Generalized Lipoatrophy, Insulin-Resistant Diabetes, Disseminated Leukomelanodermic Papules, Liver Steatosis, and CardiomyopathyThe Journal of Clinical Endocrinology & Metabolism, 2003
- Mandibuloacral Dysplasia Is Caused by a Mutation in LMNA-Encoding Lamin A/CThe American Journal of Human Genetics, 2002